Page 81 - Avian Virology: Current Research and Future Trends

74 | Samal
hemagglutinin-neuraminidase protein that interfere with its ability to protein of velogenic strains in the context of a mesogenic recombinant
interact with the homologous F protein in the promotion of fusion. virus backbone. Virus Res. 129, 182–190.
Virology 253, 43–54. Fan, W., Xu, Y., Zhang, P., Chen, P., Zhu, Y., Cheng, Z., Zhao, X., Liu, Y., and
Diel, D.G., da Silva, L.H., Liu, H., Wang, Z., Miller, P.J., and Afonso, C.L. Liu, J. (2017). Analysis of molecular evolution of nucleocapsid protein
(2012). Genetic diversity of avian paramyxovirus type 1: proposal for in Newcastle disease virus. Oncotarget 8, 97127–97136. https://doi.
a unified nomenclature and classification system of Newcastle disease org/10.18632/oncotarget.21373
virus genotypes. Infect. Genet. Evol. 12, 1770–1779. https://doi. Fiola, C., Peeters, B., Fournier, P., Arnold, A., Bucur, M., and Schirrmacher,
org/10.1016/j.meegid.2012.07.012 V. (2006). Tumor selective replication of Newcastle disease virus:
Dimitrov, K.M., Ramey, A.M., Qiu, X., Bahl, J., and Afonso, C.L. (2016). association with defects of tumor cells in antiviral defence. Int. J. Cancer
Temporal, geographic, and host distribution of avian paramyxovirus 1 119, 328–338. https://doi.org/10.1002/ijc.21821
(Newcastle disease virus). Infect. Genet. Evol. 39, 22–34. Fournier, P., and Schirrmacher, V. (2013). Oncolytic Newcastle Disease
Dimitrov, K.M., Abdolnik, C., Afonso, C. L., Albina, E., Bahl, J., Berg, M., virus as cutting edge between tumor and host. Biology 2, 936–975.
Briand, F., Brown, I. H., Choi, K., Chrala, I., et al. (2019). Updated https://doi.org/10.3390/biology2030936
unified phylogenetic classification system and revised nomenclature for Fournier, P., Wilden, H., and Schirrmacher, V. (2012). Importance of
Newcastle disease virus. Infect. Genet. Evol. 74, 103917 retinoic acid-inducible gene I and of receptor for type I interferon for
DiNapoli, J.M., Kotelkin, A., Yang, L., Elankumaran, S., Murphy, B.R., cellular resistance to infection by Newcastle disease virus. Int. J. Oncol.
Samal, S.K., Collins, P.L., and Bukreyev, A. (2007a). Newcastle disease 40, 287–298. https://doi.org/10.3892/ijo.2011.1222
virus, a host range-restricted virus, as a vaccine vector for intranasal Fuller, C.M., Collins, M.S., Easton, A.J., and Alexander, D.J. (2007).
immunization against emerging pathogens. Proc. Natl. Acad. Sci. U.S.A. Partial characterisation of five cloned viruses differing in pathogenicity,
104, 9788–9793. obtained from a single isolate of pigeon paramyxovirus type 1 (PPMV-1)
DiNapoli, J.M., Yang, L., Suguitan, A., Elankumaran, S., Dorward, D.W., following passage in fowls’ eggs. Arch. Virol. 152, 1575–1582.
Murphy, B.R., Samal, S.K., Collins, P.L., and Bukreyev, A. (2007b). García-Sastre, A., Cabezas, J.A., and Villar, E. (1989). Proteins
Immunization of primates with a Newcastle disease virus-vectored of Newcastle disease virus envelope: interaction between the
vaccine via the respiratory tract induces a high titer of serum neutralizing outer hemagglutinin-neuraminidase glycoprotein and the inner
antibodies against highly pathogenic avian influenza virus. J. Virol. 81, non-glycosylated matrix protein. Biochim. Biophys. Acta 999, 171–175.
11560–11568. Ge, J., Deng, G., Wen, Z., Tian, G., Wang, Y., Shi, J., Wang, X., Li, Y., Hu,
DiNapoli, J.M., Nayak, B., Yang, L., Finneyfrock, B.W., Cook, A., Andersen, S., Jiang, Y., et al. (2007). Newcastle disease virus-based live attenuated
H., Torres-Velez, F., Murphy, B.R., Samal, S.K., Collins, P.L., et al. (2010). vaccine completely protects chickens and mice from lethal challenge of
Newcastle disease virus-vectored vaccines expressing the hemagglutinin homologous and heterologous H5N1 avian influenza viruses. J. Virol. 81,
or neuraminidase protein of H5N1 highly pathogenic avian influenza 150–158.
virus protect against virus challenge in monkeys. J. Virol. 84, 1489–1503. Ge, J., Wang, X., Tao, L., Wen, Z., Feng, N., Yang, S., Xia, X., Yang, C., Chen,
https://doi.org/10.1128/JVI.01946-09 H., and Bu, Z. (2011). Newcastle disease virus-vectored rabies vaccine
Dortmans, J.C., Koch, G., Rottier, P.J., and Peeters, B.P. (2009). Virulence is safe, highly immunogenic, and provides long-lasting protection
of pigeon paramyxovirus type 1 does not always correlate with the in dogs and cats. J. Virol. 85, 8241–8252. https://doi.org/10.1128/
cleavability of its fusion protein. J. Gen. Virol. 90, 2746–2750. JVI.00519-11
Dortmans, J.C., Rottier, P.J., Koch, G., and Peeters, B.P. (2010). The viral Ge, J., Wang, X., Tian, M., Gao, Y., Wen, Z., Yu, G., Zhou, W., Zu, S., and
replication complex is associated with the virulence of Newcastle disease Bu, Z. (2015). Recombinant Newcastle disease viral vector expressing
virus. J. Virol. 84, 10113–10120. https://doi.org/10.1128/JVI.00097-10 hemagglutinin or fusion of canine distemper virus is safe and
Doyle, T. (1927). A hitherto unrecorded disease of fowls due to a immunogenic in minks. Vaccine 33, 2457–2462.
filter-passing virus. J. Comp. Pathol. Therap. 40, 144–169. Ghumman, J.S., and Bankowski, R.A. (1976). In vitro DNA synthesis in
Duan, Z., Song, Q., Wang, Y., He, L., Chen, J., Zhu, Y., Hu, S., and Liu, X. lymphocytes from turkeys vaccinated with LaSota, TC, and inactivated
(2013). Characterization of signal sequences determining the nuclear Newcastle disease vaccines. Avian Dis. 20, 18–31.
export of Newcastle disease virus matrix protein. Arch. Virol. 158, Glaser, L.C., Barker, I.K., Weseloh, D.V., Ludwig, J., Windingstad, R.M.,
2589–2595. https://doi.org/10.1007/s00705-013-1769-5 Key, D.W., and Bollinger, T.K. (1999). The 1992 epizootic of Newcastle
Duan, Z., Chen, J., Xu, H., Zhu, J., Li, Q., He, L., Liu, H., Hu, S., and Liu, disease in double-crested cormorants in North America. J. Wildl. Dis. 35,
X. (2014). The nucleolar phosphoprotein B23 targets Newcastle 319–330. https://doi.org/10.7589/0090-3558-35.2.319
disease virus matrix protein to the nucleoli and facilitates viral Goebel, S.J., Taylor, J., Barr, B.C., Kiehn, T.E., Castro-Malaspina, H.R.,
replication. Virology 452–453, 212–222. https://doi.org/10.1016/j. Hedvat, C.V., Rush-Wilson, K.A., Kelly, C.D., Davis, S.W., Samsonoff,
virol.2014.01.011 W.A., et al. (2007). Isolation of avian paramyxovirus 1 from a patient
Ecco, R., Susta, L., Afonso, C.L., Miller, P.J., and Brown, C. (2011). with a lethal case of pneumonia. J. Virol. 81, 12709–12714.
Neurological lesions in chickens experimentally infected with virulent Goff, P.H., Gao, Q., and Palese, P. (2012). A majority of infectious Newcastle
Newcastle disease virus isolates. Avian Pathol. 40, 145–152. https://doi. disease virus particles contain a single genome, while a minority contain
org/10.1080/03079457.2010.544289 multiple genomes. J. Virol. 86, 10852–10856. https://doi.org/10.1128/
Edwards, J. (1928). A new fowl disease. Mukteswar Ann. Rep. Inp. Inst. Vet. JVI.01298-12
Res. 31, 14–15. Gough, R.E., and Alexander, D.J. (1973). The speed of resistance to challenge
Elankumaran, S., Rockemann, D., and Samal, S.K. (2006). Newcastle disease induced in chickens vaccinated by different routes with a B1 strain of live
virus exerts oncolysis by both intrinsic and extrinsic caspase-dependent NDV. Vet. Rec. 92, 563–564.
pathways of cell death. J. Virol. 80, 7522–7534. Gould, A.R., Kattenbelt, J.A., Selleck, P., Hansson, E., Della-Porta, A.,
Elankumaran, S., Chavan, V., Qiao, D., Shobana, R., Moorkanat, G., Biswas, and Westbury, H.A. (2001). Virulent Newcastle disease in Australia:
M., and Samal, S.K. (2010). Type I interferon-sensitive recombinant molecular epidemiological analysis of viruses isolated prior to and during
Newcastle disease virus for oncolytic virotherapy. J. Virol. 84, 3835– the outbreaks of 1998-2000. Virus Res. 77, 51–60.
3844. https://doi.org/10.1128/JVI.01553-09 Gould, A.R., Hansson, E., Selleck, K., Kattenbelt, J.A., Mackenzie,
Erdei, J., Erdei, J., Bachir, K., Kaleta, E.F., Shortridge, K.F., and Lomniczi, B. M., and Della-Porta, A.J. (2003). Newcastle disease virus fusion
(1987). Newcastle disease vaccine (La Sota) strain specific monoclonal and haemagglutinin-neuraminidase gene motifs as markers
antibody. Brief report. Arch. Virol. 96, 265–269. for viral lineage. Avian Pathol. 32, 361–373. https://doi.
Errington, W., and Emmerson, P.T. (1997). Assembly of recombinant org/10.1080/0307945031000121112
Newcastle disease virus nucleocapsid protein into nucleocapsid-like Granoff, A. (1959a). Studies on mixed infection with Newcastle disease
structures is inhibited by the phosphoprotein. J. Gen. Virol. 78, 2335– virus. I. Isolation of Newcastle disease virus mutants and tests for genetic
2339. https://doi.org/10.1099/0022-1317-78-9-2335 recombination between them. Virology 9, 636–648.
Estevez, C., King, D., Seal, B., and Yu, Q. (2007). Evaluation of Newcastle Granoff, A. (1959b). Studies on mixed infection with Newcastle disease
disease virus chimeras expressing the hemagglutinin-neuraminidase virus. II. The occurrence of Newcastle disease virus heterozygotes and